New Inversion Rules Force Pfizer to End Deal With Allergan

Pfizer said it would walk away from its planned $150 billion takeover of Allergan, after the Obama administration took aim at a deal that would have moved the biggest drug company in the U.S. to Ireland to lower its taxes.